HERMES INVESTMENT MANAGEMENT LTD - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 169 filers reported holding HAEMONETICS CORP in Q1 2015. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
HERMES INVESTMENT MANAGEMENT LTD ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2017$29,999,000
+10.2%
668,586
-3.0%
0.45%
+1.6%
Q2 2017$27,213,000
-12.7%
689,111
-10.4%
0.44%
-12.3%
Q1 2017$31,187,000
+2.2%
768,733
+1.3%
0.50%
-3.1%
Q4 2016$30,514,000
+25.5%
759,050
+13.0%
0.52%
+26.2%
Q3 2016$24,316,000
+33.9%
671,536
+7.2%
0.41%
+13.2%
Q2 2016$18,166,000
-0.2%
626,624
+21.5%
0.36%
-4.2%
Q1 2016$18,195,000
-9.6%
515,595
-17.5%
0.38%
-16.3%
Q4 2015$20,137,000
+3.6%
624,598
+3.9%
0.46%
-9.2%
Q3 2015$19,438,000
-22.5%
601,427
-0.8%
0.50%
-11.2%
Q2 2015$25,074,000
-6.2%
606,237
+1.9%
0.56%
-9.0%
Q1 2015$26,722,000
+36.4%
594,882
+13.7%
0.62%
+23.0%
Q4 2014$19,586,000
-11.9%
523,408
-17.7%
0.50%
-11.7%
Q3 2014$22,220,000
+0.7%
636,317
+1.8%
0.57%
-6.4%
Q2 2014$22,059,000
-7.0%
625,249
-14.1%
0.61%
-18.4%
Q1 2014$23,730,000
-23.4%
728,123
-0.9%
0.75%
-20.8%
Q4 2013$30,964,000
+1025.1%
734,973
+965.0%
0.94%
+916.1%
Q3 2013$2,752,000
-3.6%
69,0140.0%0.09%
-16.2%
Q2 2013$2,854,00069,0140.11%
Other shareholders
HAEMONETICS CORP shareholders Q1 2015
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders